References
  1. Moch H, Humphrey PA, Ulbright TM, Reuter VE, eds. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon, France: IARC; 2016. World Health Organization Classification of Tumours; vol 8.
  2. Ning Yi Yap, Retnagowri Rajandram, Keng Lim Ng, Jayalakshmi Pailoor, Ahmad Fadzli, Glenda Carolyn Gobe. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms. BioMed Research International 2015;volume 2015: Article ID 476508.
  3. Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med. 2011 Jan;135(1):92-109.
  4. Lew M, Foo WC, Roh MH. Diagnosis of metastatic renal cell carcinoma on fine-needle aspiration cytology. Arch Pathol Lab Med. 2014 Oct;138(10):1278-85.
  5. Layfield LJ. Atlas of Fine Needle Aspiration Cytology. Jaypee Brothers Medical Pub; 1 edition (March 1, 2014)
  6. Riely GJ, Marks J, Pao W. KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc. 2009;6(2):201-5
  7. Riely GJ, Yu HA. EGFR: The Paradigm of an Oncogene-Driven Lung Cancer. Clin Cancer Res. 2015;21(10):2221-6.
  8. Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H, Panel IRT. Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol. 2013;37:1518–1531